(firstQuint)Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer.

 This is a phase Ib/II clinical trial.

 DPX-E7 is a therapeutic vaccine, intended to treat HPV-related head and neck, cervical or anal cancer.

 DPX-E7 is an investigational vaccine and the FDA (the U.

S.

 Food and Drug Administration) has not approved DPX-E7 vaccine as a treatment for any disease.

 DPX-E7 is being tested in humans for the first time.

 DPX-E7 is a kind of immunotherapy that will make the immune system to elicit an anti-tumor response by generating CD8+ T-cells.

 CD8+ T-cells play a very important role in fighting against viral infections Cyclophosphamide is used to treat various types of cancer.

 It is a biological modifier drug that works by slowing or stopping cell growth.

.

 Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer@highlight

This research study is studying a therapeutic vaccine, named DPX-E7, as a possible treatment for Human Papilloma Virus or HPV related head and neck, cervical or anal cancer (positive for HLA-A*02).

